PS

Poonam Singh

Active Director Director DIN 10271860
DIN 10271860 First appointment Sep 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value •••• Premium profile

About Poonam Singh

Data last updated:

Poonam Singh is a Director at Affix Pharmaceuticals Private Limited (since 2023). The company operates in Trading. Affix Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh (FY 2025).

DIN 10271860
Primary Designation Director
Industry Trading
First Appointment 01 Sep 2023
Oldest Company Age 11 yrs
Largest company Affix Pharmaceuticals Private Limited · ₹4.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20232015₹4.8 Lakh (FY 2025)Active

Board colleagues of Poonam Singh

Directorship timeline

Open interactive timeline →
Affix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poonam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Singh

Poonam Singh currently holds 1 directorship: Affix Pharmaceuticals Private Limited (Director, since 01 Sep 2023, revenue ₹4.8 Lakh (FY 2025)).

Poonam Singh was first appointed on 01 Sep 2023 as Director at Affix Pharmaceuticals Private Limited.

The current boards of Poonam Singh's companies include Garima Singh (Affix Pharmaceuticals Private Limited), Rajnish Kumar Singh (Affix Pharmaceuticals Private Limited), Ritesh Singh (Affix Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available